ChiCTR2000040298: Bioequivalence of Theophylline Extended-release Tablets in the Healthy Human Body: a Randomized Cross-Over Controlled Trial |
|
|
| Not yet recruiting | 1 | 48 | | Theophylline Extended-release Tablets (Theophylline 300 mg/Tablet) (Vickmans Laboratories Ltd., Hong Kong) versus Theophylline Extended-release Tablets (Theophylline 300 mg/Tablet) (AdcockIngram Limited, India) ;Theophylline Extended-release Tablets (Theophylline 300 mg/Tablet) (AdcockIngram Limited, India) versus Theophylline Extended-release Tablets (Theophylline 300 mg/Tablet) (Vickmans Laboratories Ltd., Hong Kong) | Xiangya Boai Rehabilitation Hospital; Xiangya Boai Rehabilitation Hospital, Vickmans Laboratories Ltd. | Pharmacokinetics and Bioequivalence Study in human | | | | |
| Withdrawn | 1 | 0 | US | Theophylline ER, PO placebo, Lipopolysaccharide (LPS), IV placebo | University of California, Los Angeles | Depression | 06/25 | 06/25 | | |
